Vaginal Progesterone for the Prevention of Preterm Birth in Twins
Status:
Withdrawn
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This trial is a randomised, multi-centre, 2 x 2 factorial designed pilot trial with two
factors of 200mg vs. 400mg progesterone self-administered daily from 11-14 weeks' gestation
vs. 20-24 weeks' gestation, to compare the median gestational age (in days) at delivery
between the comparison groups.